Ipsos Healthcare launches chronic disease study
The studies will start with Psoriatic Arthritis and look at patient perspective on the quality of life, medication, and pathway to diagnosis, and aims to help pharmaceutical and biotech companies identify wider patient-level and market opportunities.
Initially available in the UK, France, Italy, Spain and the US, they will be delivered in collaboration between the disease experts from Ipsos Healthcare’s Global Therapy Monitors teams, and the anthropologically trained researchers from Ipsos’ Ethnography Centre of Excellence.
Victoria Guyatt, deputy head of Ethnography at the qualitative research arm Ipsos UU said: “Ultimately, ethnography has the power to change the way the pharma / biotech industry views patients, putting them at the centre of decision-making.”
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
1 Comment
Armando Abrero
12 years ago
I see the wisdom of ethnography in disease research. As true in every rare disease, only real patients can describe with precision how it is to feel and live with psoriatic arthritis. Easiest way to find real patients is through online support sites such as http://www.livingwithpsoriaticarthritis.org/, which has close to 1500 members and growing. If you suffer from the illness, or conducting a research on it, you might want to check out the site. Signing up is a breeze and the moderators are just so warm and friendly.
Like Reply Report